Zoetis (LTS:0M3Q) Short Percentage of Float


LTS:0M3Q Zoetis Inc LTS:0M3Q
78 GF Score
Price $76.75
GF Value $193.54
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


LTS:0M3Q vs UTHR, VTRS, NBIX: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zoetis Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zoetis's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Zoetis's Short Percentage of Float falls into.


LTS:0M3Q
78GF Score
Zoetis Inc LTS:0M3Q
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zoetis (LTS:0M3Q) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of $76.75 is trading 60.3% below its estimated GF Value™ of $193.54. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for LTS:0M3Q:

  • Short Percentage of Float:
  • GF Value™: $193.54 vs. price of $76.75 (60.3% below fair value)
  • GF Score™: 78/100

No single metric tells the full story. See the LTS:0M3Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
78GF Score

Get the complete analysis for LTS:0M3Q

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$76.75
Price
$193.54
GF Value